Tag: Aflibercept

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aflibercept

Phase 2 data on IBI302 announced by Innovent Biologics - Ophthalmology Times

Added to Collection on: 2025-05-07 19:45:50

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Anti-VEGF
Dose
Macular degeneration
Brolucizumab
Faricimab
innovent biologics
Innovent
Xiaodong Sun

Click the tags to see associated articles and topics

View Article Details
Innovent Biologics completes first patient dosing in its phase 2 clinical trial assessing ...

Added to Collection on: 2025-05-08 16:05:55

Tags for this article:

Angiogenesis inhibitors
Blindness
Diabetic retinopathy
Anti-VEGF
Faricimab
Macular edema
Vascular endothelial growth factor
Macular degeneration
Intravitreal administration
Bispecific monoclonal antibody
Conbercept
Aflibercept
innovent biologics
Innovent

Click the tags to see associated articles and topics

View Article Details
Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the ...

Added to Collection on: 2025-06-10 12:13:24

Tags for this article:

Blindness
Diabetic retinopathy
Angiogenesis inhibitors
Macular edema
Macular degeneration
Vascular endothelial growth factor
Aflibercept
Intravitreal gene therapy

Click the tags to see associated articles and topics

View Article Details
NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis ...

Added to Collection on: 2025-07-27 14:44:48

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Monoclonal antibodies
Macular edema
Diabetic retinopathy
Anti-VEGF
Intravitreal administration
Clinical endpoint
Faricimab
Fluocinolone acetonide
ANI Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
VABYSMO® (faricimab injection) Now Publicly Funded For Macular Edema Secondary to ...

Added to Collection on: 2025-08-15 19:02:23

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Blindness
Faricimab
Macular edema
Diabetic retinopathy
Aflibercept
Central retinal vein occlusion
Branch retinal vein occlusion
Macular degeneration
Retina
Retinopathy
HOFFMANN-LA ROCHE LIMITED
Roche Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Outlook Therapeutics plunges more than 52% after FDA rejects wet AMD drug

Added to Collection on: 2025-08-28 23:46:55

Tags for this article:

Angiogenesis inhibitors
Orphan drugs
Food and Drug Administration
Bevacizumab
Roche
Aflibercept
Macular degeneration
United States

Click the tags to see associated articles and topics

View Article Details
REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock? - TradingView

Added to Collection on: 2025-09-15 15:32:00

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Macular edema
Bayer
Dupilumab
Cemiplimab
Central retinal vein occlusion
Priority review
Eylea
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
6 FDA Decisions to Watch For in Q4 - BioSpace

Added to Collection on: 2025-09-29 04:24:09

Tags for this article:

Orphan drugs
Cancer treatments
Antineoplastic drugs
Aflibercept
Sanofi
Plozasiran
Regeneron Pharmaceuticals
Macular edema
Lisocabtagene maraleucel

Click the tags to see associated articles and topics

View Article Details
VABYSMO® (faricimab injection) Now Publicly Funded for Macular Edema Secondary to ...

Added to Collection on: 2025-09-29 14:46:28

Tags for this article:

Angiogenesis inhibitors
Retinopathy
Monoclonal antibodies
Blindness
Faricimab
Macular edema
Aflibercept
Diabetic retinopathy
Central retinal vein occlusion
Branch retinal vein occlusion
Macular degeneration
Retina
HOFFMANN-LA ROCHE LIMITED
Roche Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
ANVISA approves ranibizumab and tocilizumab biosimilars

Added to Collection on: 2025-10-03 15:51:43

Tags for this article:

Orphan drugs
Angiogenesis inhibitors
Monoclonal antibodies
Ranibizumab
Biosimilar
Bevacizumab
Vascular endothelial growth factor
Tocilizumab
Macular degeneration
Roche
Anti-VEGF
Aflibercept
Actemra
fresenius kabi

Click the tags to see associated articles and topics

View Article Details
Book a Demo